-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Ensysce Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q4 2024.
- Ensysce Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 698K shares, a 362% increase year-over-year.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 698K shares, a 362% increase from 2023.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 151K shares, a 16.1% decline from 2022.
- Ensysce Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 180K shares, a 99.1% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)